Taxifolin
規格
24198-97-8CAS番号
207-543-4EC番号
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-oneIUPAC名
C15H12O7化学式
304.25 g/mol分子量
TAXIFOLIN; 480-18-2; (+)-Taxifolin; Distylin; Taxifoliol; (+)-Dihydroquercetin; (2R,3R)-Dihydroquercetin; Lavitol; Diquertin; 2,3-Dihydroquercetin; Flamena D; (2R,3R)-3,3',4',5,7-Pentahydroxyflavanone; (2R,3R)-(+)-Taxifolin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; trans-Dihydroquercetin; (+)-(2R,3R)-dihydroquercetin; (2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE; DTXSID8022450; Flavanone, 3,3',4',5,7-pentahydroxy-; 9SOB9E3987; CHEBI:17948; CHEBI:38747; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one; RefChem:6285; DTXCID502450; 207-543-4; Catechin hydrate; dihydroquercetin; 24198-97-8; (+/-)-Taxifolin; 17654-26-1; (+/-)-dihydroquercetin; TAXIFOLIN-(+); Lariksin; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one; (+)-trans-Taxifolin; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one; taxifolin (dihydroquercetin); (+)-trans Taxifolin; (2R-trans)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4-benzopyrone; Taxifolin, (+/-)-; (+/-)-trans Taxifolin; EAS93SC1VS; Dihydroquercetin, (+/-)-; (2R,3R)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; ( inverted exclamation markA)-Taxifolin; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-one; rel-(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one; rel-(2R,3R)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; (?)-Taxifolin; MFCD00006845; 3,3',4',5,7-Pentahydroxyflavanone; (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R-trans)-; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, trans-(+/-)-; DQH; SMR000466389; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-; (+/-)-Taxifolin hydrate; taxifoline; toxifolin; UNII-9SOB9E3987; CCRIS 9292; Taxifolin CRS; (+)-Dihydroquercetin; (+)-Taxifolin; Acetin,di-; Taxifolin (Tax); ()-Taxifolin; EINECS 207-543-4; FLAMENA; 3,3',4',5,7-Pentahydroxyflavanone hydrate; Taxifolin (Standard); (2R,3R)-TRANS-DIHYDROQUERCETIN; BRN 0093548; (2R,3R)-Taxifolin; Dihydroquercetin (DHQ); UNII-EAS93SC1VS; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-one; SCHEMBL39786; 5-18-05-00451 (Beilstein Handbook Reference); MLS000759539; MLS001066341; MLS001074712; MLS001424044; MLS002153142; BIDD:ER0483; Taxifolin, analytical standard; Flavone, 2,3-dihydro-3,3',4',5,7-pentahydroxy-; MEGxp0_000741; orb1221587; orb1224985; orb1307570; orb1690847; orb2900930; orb3140013; SCHEMBL29361519; SCHEMBL29367955; SCHEMBL30631315; ACon1_000239; HY-N0136R; DIHYDROQUERCETIN [WHO-DD]; WLZ4646; BDBM212435; DTXSID301017215; HMS2051M22; HMS2234L14; HY-N0136; AC-935; LMPK12140721; MFCD11044454; MSK174293; s2366; AKOS015965399; (+/-)-Taxifolin - Bio-X trade mark; CCG-100909; CS-3365; DB02224; EBC-223039; FT28009; FT28010; KS-1312; NC00159; NCGC00016024-08; NCGC00016024-13; NCGC00180750-01; 20254-28-8; AS-17723; BT300132; DIHYDROQUERCETIN, (+)-(2R,3R)-; NS00015857; SW197539-2; ( inverted exclamation markA)-Dihydroquercetin; C01617; G12170; T40080; (2R,3R)-3,5,7,3',4'-Pentahydroxyflavanone; F814314; Q412191; SR-01000759385; Flavanone, 3,3',4',5,7-pentahydroxy-, (R,R)-; SR-01000759385-6; Taxifolin, primary pharmaceutical reference standard; BRD-K94649603-001-10-6; BRD-K94649603-001-11-4; F40AB773-26FA-4112-A46D-DC970AF64BC1; Flavanone, 3,3',4',5,7-pentahydroxy-, (2R)-trans-; Flavanone, 3,3',4',5,7-pentahydroxy-, trans-(+)-; (+)-TAXIFOLIN (CONSTITUENT OF MARITIME PINE) [DSC]; (+)-TAXIFOLIN (CONSTITUENT OF MILK THISTLE) [DSC]; Flavanone, 3,3',4',5,7-pentahydroxy-, (2R,3R)-(+)-; (2R,3R)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one, (2R-trans)-別名
